These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Usefulness of invasive and non-invasive electrophysiologic studies in the selection of antiarrhythmic drugs for the patients with paroxysmal supraventricular tachyarrhythmia. Satake S, Hiejima K, Moroi Y, Hirao K, Kubo I, Suzuki F, Suzuki F. Jpn Circ J; 1985 Mar; 49(3):345-50. PubMed ID: 3981793 [Abstract] [Full Text] [Related]
7. Effect of disopyramide on initiation of atrial fibrillation and relation to effective refractory period. Ito M, Onodera S, Hashimoto J, Noshiro H, Shinoda S, Nagashima M, Suzuki H. Am J Cardiol; 1989 Mar 01; 63(9):561-6. PubMed ID: 2919560 [Abstract] [Full Text] [Related]
15. [Evaluation of drug efficacy for preventing paroxysmal atrial fibrillation]. Fujiki A, Yoshida S, Tani M, Sasayama S. Jpn Circ J; 1992 Apr 01; 56 Suppl 5():1454-7. PubMed ID: 1291741 [No Abstract] [Full Text] [Related]
16. [Effects of intravenous disopyramide on induction and termination of paroxysmal supraventricular tachycardia via an accessory pathway]. Komatsu C, Ishinaga T, Tateishi O, Tokuhisa Y, Hara M, Sanada T, Kanae K, Satoh Y, Yoshimura S. Kokyu To Junkan; 1984 Apr 01; 32(4):409-14. PubMed ID: 6463419 [No Abstract] [Full Text] [Related]